Congratulations to CPI scientist Eduardo Vilar-Sanchez, MD, PhD, who has been recognized by the American Society of Clinical Oncology (ASCO) with one of the society’s highest honors as the 2026 recipient of the ASCO—American Cancer Society Cancer Prevention Award.

ASCO Congratulates 2026 Special Award Recipients | ASCO Connection

ASCO-American Cancer Society Cancer Prevention Award 2026

Eduardo Vilar-Sanchez, MD, PhD

Dr. Vilar-Sanchez is professor and Chair, ad interim, of the Department of Clinical Cancer Prevention, at the University of Texas MD Anderson Cancer Center. He is a physician-scientist and medical oncologist specializing in Hereditary Cancer syndromes, with a focus on Lynch Syndrome (LS) and Familial Adenomatous Polyposis (FAP). His work bridges the gap between molecular discovery and clinical application, aiming to understand colorectal carcinogenesis and develop novel cancer interception strategies. His lab is at the forefront of identifying neoantigens for preventive vaccines and exploring how pharmacological agents, like naproxen, and lifestyle interventions, such as exercise, modulate the immune environment. Through these efforts, Dr. Vilar-Sanchez is transforming cancer prevention into a personalized, proactive discipline for genetically predisposed patients and their families.